15 December 2011
A new cancer treatment drug could be used for 70 per cent of all cancers, according to latest reports.
Scientists have developed a vaccine that could tackle cancers, including prostate, pancreatic, bowel and ovarian.
Furthermore, testing has suggested that tumours that are not responsive to the best medicine currently used - including the drug Herceptin - could be reactive to the new treatment.
Tests have been done only on mice so far, but it is expected that a clinical trial of the vaccine will shortly follow.
Professor Geert-Jan Boons, co-author of the study, said: "This vaccine elicits a very strong immune response. It activates all three components of the immune system to reduce tumour size by an average of 80 per cent."
He added that the most significant result found was in mice with breast tumours, where the lump considerably reduced in size.
According to herceptin.com, around one in four breast cancer patients has HER2+ breast cancer, which is treatable with the drug Herceptin.
Posted by Philip Briggs
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.